Evidence map›Paper›PMID 34866344›Full record

ArticleInfluenza and other respiratory viruses2022

A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom.

Thierry Rigoine de Fougerolles, Joan Puig-Barbera, George Kassianos, Philippe Vanhems, Jorg Schelling, Pascal Crepey, Raul Ortiz de Lejarazu, Filippo Ansaldi, Markus Fruhwein, Cristina Galli and 7 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Thierry Rigoine de FougerollesCVA, Healthcare Practice, Paris, France.
Joan Puig-BarberaVaccines Research, Fisabio, Valencia, Spain.ORCID 0000-0001-5783-0409
George KassianosRoyal College of General Practitioners, UK and British Global & Travel Health Association, London, UK.
Philippe VanhemsDepartment of Hygiene and Epidemiology, Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID) - Inserm - U1111 - UCBL, Lyon University Hospital and Centre International de Recherche en Infectiologie (CIRI), Lyon, France.ORCID 0000-0003-3188-1456
Jorg SchellingMedical Faculty, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0002-5872-2335
Pascal CrepeySchool of Advanced Studies in Public Health, University of Rennes, Rennes, France.
Raul Ortiz de LejarazuValladolid NIC, University of Valladolid, Valladolid, Spain.
Filippo AnsaldiDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Markus FruhweinDr. Fruehwein & Partners, Practise for General Medicine, Travel Medicine and Tropical Diseases, Munich, Germany.
Cristina GalliDepartment of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Anne MosnierRéseau des GROG, Open Rome, Paris, France.
Elena ParianiDepartment of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Anvar RasuliMedical Department, Sanofi Pasteur, Lyon, France.
Olivier VitouxCVA, Healthcare Practice, Paris, France.
John WatkinsDivision of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.
Thomas WeinkeKlinikum Ernst von Bergmann, Medizinische Klinik, Gastroenterologie, Infektiologie, Pneumologie, Potsdam, Germany.
Hélène BricoutMedical Department, Sanofi Pasteur, Lyon, France.ORCID 0000-0002-5439-8064

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn response to the coronavirus disease (COVID-19) outbreak that unfolded across Europe in 2020, the World Health Organisation (WHO) called for repurposing existing influenza surveillance systems to monitor COVID-19. This analysis aimed to compare descriptively the extent to which influenza surveillance systems were adapted and enhanced and how COVID-19 surveillance could ultimately benefit or disrupt routine influenza surveillance.

methodsWe used a previously developed framework in France, Germany, Italy, Spain and the United Kingdom to describe COVID-19 surveillance and its impact on influenza surveillance. The framework divides surveillance systems into seven subsystems and 20 comparable outcomes of interest and uses five evaluation criteria based on WHO guidance. Information on influenza and COVID-19 surveillance systems were collected from publicly available resources shared by European and national public health agencies.

resultsOverall, non-medically attended, virological, primary care and mortality surveillance were adapted in most countries to monitor COVID-19, although community, outbreak and hospital surveillance were reinforced in all countries. Data granularity improved, with more detailed demographic and medical information recorded. A shift to systematic notification for cases and deaths enhanced both geographic and population representativeness, although the sampling strategy benefited from the roll out of widespread molecular testing. Data communication was greatly enhanced, contributing to improved public awareness.

conclusionsWell-established influenza surveillance systems are a key component of pandemic preparedness, and their upgrade allowed European countries to respond to the COVID-19 pandemic. However, uncertainties remain on how both influenza and COVID-19 surveillance can be jointly and durably implemented.

Indexed as

COVID-19Influenza, HumanEuropeFranceGermanyHumansItalyPandemicsSeasonsSpainUnited KingdomburdenCOVID-19epidemiologyEuropeinfluenzasurveillance

Identifiers

PMID34866344
PMCPMC8983920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.